Tag Archives: Dr David Strayer

Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)

Research abstract: Background: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a debilitating disease of unknown pathogenesis consisting of  a variety of flu-like symptoms including severe fatigue. Initial analysis of the use of rintatolimod (Poly I: Poly C12U), a selective TLR3 agonist, … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)

XMRV found in CFS patients by NGS lab test

Dr Paul Cheney, a leading CFS expert physician in America for years, reports that XMRV was found in 7 of 8 CFS patients but only in 2 of 17 non-CFS people (controls) in a study reported by Dr David Strayer … Continue reading

Posted in News | Tagged , , , , , | Comments Off on XMRV found in CFS patients by NGS lab test